CareDx (CDNA) Prices 1.92M Share Common Offering at $91/Sh

Pre-Open Stock Movers 01/20: (APM) (EVLO) (NFLX) Higher; (GEVO) (HSTO) (BLRX) Lower (more...)

Pre-Open Stock Movers:

Aptorum Group Limited (NASDAQ: APM) 42.8% HIGHER; announced that the company, through its wholly owned subsidiary, Aptorum International Limited, has received clearance from the Public Health Agency of Canada (Health Canada) regarding the Clinical Trial Application (CTA) to commence a Phase 1 study of ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus including MRSA.

Gevo (NASDAQ: GEVO) 21.6% LOWER; announced that it has entered into definitive agreements... More

After-Hours Stock Movers 01/19: (NFLX) (CKPT) (PCAR) Higher; (HSTO) (BLRX) (ACRX) Lower (more...)

After-Hours Stock Movers:

Histogen Inc. (NASDAQ: HSTO) 16.5% LOWER; announced that the U.S. Food and Drug Administration (FDA) has verbally notified the company that it has additional questions about the companys Investigational New Drug (IND) application package for the planned Phase 1/2 clinical trial of HST-003, which is intended to evaluate the safety and efficacy of human extracellular matrix (hECM:HST-003) implanted within microfracture interstices and the cartilage defect in the knee to regenerate hyaline cartilage in combination with a microfracture procedure.

BioLineRx Ltd. (NASDAQ:... More

CareDx (CDNA) Announces $175M Proposed Public Offering of Common Stock

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it intends to offer and sell, subject to market and other conditions, up... More